Protocol Title: A Randomized, Phase 3, Double-Masked, Parallel-Group, Multicenter Study to Compare the Efficacy and Safety of ALT-L9 Versus Eylea® in Patients With Neovascular Age-Related Macular Degeneration (ALTERA)

  • Casazza, Marina (Researcher)
  • Eidherr, Markus (Researcher)
  • Khalil, Haidar (Researcher)
  • Murauer, Olivia (Researcher)
  • Waser, Klemens (Researcher)
  • Bolz, Matthias (PI)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

Protocol Title: A Randomized, Phase 3, Double-Masked, Parallel-Group, Multicenter Study to Compare the Efficacy and Safety of ALT-L9 Versus Eylea® in Patients With Neovascular Age-Related Macular Degeneration (ALTERA)
StatusFinished
Effective start/end date03.10.2022 → 01.03.2024

Fields of science

  • 302007 Ophthalmology